Cite
HARVARD Citation
Phillips, H. et al. (2016). Achievement of European atherosclerosis society (EAS) targets with lomitapide, a microsomal transfer protein inhibitor in homozygous familial hypercholesterolaemia (HoFH). Atherosclerosis. pp. e33-. [Online].